What is the recommended dosage of Myobloc (botulinum toxin) for treating glabella frown lines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Myobloc (Botulinum Toxin B) for Glabella Frown Lines

The recommended dosage of Myobloc (botulinum toxin B) for treating glabellar frown lines is 2,400-3,000 units divided among 5-6 injection sites in the glabellar region.

Dosing Guidelines for Myobloc (BTX-B)

Myobloc (botulinum toxin B) requires significantly higher unit dosing compared to botulinum toxin A products due to differences in potency and mechanism of action. Based on clinical research:

  • Starting dose range: 2,400-3,000 units total 1
  • Injection sites: Typically divided among 6 sites in the glabellar region
  • Onset of action: Rapid, with full response typically seen within 2-3 days 1
  • Duration of effect:
    • At 2,400 units: approximately 9.6 weeks
    • At 3,000 units: approximately 10.4 weeks 1

Administration Technique

For optimal results when injecting Myobloc for glabellar lines:

  1. Divide the total dose equally among injection sites (typically 5-6 points)
  2. Inject into the following muscles:
    • Corrugator supercilii muscles (2 sites in each muscle)
    • Procerus muscle (1-2 sites)
  3. Ensure proper needle placement to avoid complications:
    • Place lateral corrugator injections at least 1 cm above the bony supraorbital ridge
    • Do not inject closer than 1 cm above the central eyebrow
    • Use proper aseptic technique

Comparison with Botulinum Toxin A Products

It's important to note that Myobloc (BTX-B) dosing is significantly different from botulinum toxin A products:

  • Botulinum toxin A (Botox Cosmetic) typically requires only 20 units total for the same area 2
  • The higher unit requirement for Myobloc does not indicate greater potency, but reflects differences in formulation and biological activity

Safety Considerations

When administering Myobloc for glabellar lines, be aware of:

  • Common adverse effects: Mild pain at injection site, potential for headache 1
  • Less common adverse effects: Eyelid ptosis (reported in approximately 2-3% of patients) 1
  • Post-administration care:
    • Patients should remain upright for 3-4 hours after treatment
    • Avoid touching or massaging treated areas
    • Refrain from strenuous exercise for 24 hours
    • Avoid alcohol consumption for 24 hours 3

Clinical Pearls

  • The critical period for potential toxin spread is within the first 24-48 hours after injection 3
  • Higher doses of Myobloc appear to prolong the duration of response with minimal increase in adverse effects 1
  • Pain during injection may be reduced using a skin-vibrating device, cold air skin cooling, or topical anesthetics 3
  • Reconstituted botulinum toxin should be stored properly and used according to manufacturer guidelines

Conclusion

While Myobloc (botulinum toxin B) is effective for treating glabellar frown lines, it requires significantly higher unit dosing compared to botulinum toxin A products. The recommended dosage of 2,400-3,000 units provides approximately 9-10 weeks of effect with an acceptable safety profile.

References

Research

Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003

Guideline

Botulinum Toxin B in Aesthetic Medicine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.